Key Points
- RVI called for full scrutiny of the Public Health (Single-Use Vapes) Bill 2025;
- The bill is scheduled for debate in the Dáil on December 17;
- RVI represents over 3,300 independent vape retailers nationwide;
- The group warned of loopholes observed under similar UK legislation;
- RVI reiterated the role of vaping as a harm-reduction tool for adult smokers.
2Firsts, December 17, 2025 – Responsible Vaping Ireland (RVI) has called on TDs to ensure the Public Health (Single-Use Vapes) Bill 2025 is fully scrutinised as it comes before the Dáil for debate.
RVI, which represents more than 3,300 independent vape retailers across Ireland, said meaningful consultation with retailers and enforcement authorities will be critical to ensuring the proposed ban achieves its public health and environmental objectives without unintended consequences.
An RVI spokesperson said the organisation supports the Government’s aim of reducing underage access to vaping products and addressing environmental harm, but stressed that the legislation must be clear, enforceable and free of loopholes.
The spokesperson cited the UK’s experience with a similar ban that came into force in June, noting that minor design changes allowed some disposable products to be reclassified as reusable, undermining the intent of the law and disadvantaging compliant retailers.
RVI said it is essential that Ireland addresses these issues at Committee Stage through clear definitions and robust enforcement. The organisation also reiterated that vaping remains an important harm-reduction tool for adult smokers seeking to quit, and that flavours play a key role in helping adults stay off cigarettes.
The group urged the Government to allocate sufficient time for debate at all stages of the legislative process, stating that careful scrutiny would help deliver an effective ban aligned with Northern Ireland and resilient against future attempts to circumvent the law.
Image source: Getty
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
